Would you consider adding immunotherapy to chemotherapy in adjuvant treatment of resected small cell lung cancer?  

In the absence of data in this space, no. The improvements observed in ES-SCLC in IMpower133 and CASPIAN with the addition of ICI were modest at best. Pending results from ADRIATIC and NRG LU005 for benefits in the limited stage population, but this would still require a leap of faith to the adjuvan...